Takeda Pharmaceutical Co Ltd ADR (TAK) — Capital Reinvestment Ratio
Takeda Pharmaceutical Co Ltd ADR (TAK) has a Capital Reinvestment Ratio of 0.12x as of December 2025, meaning it reinvests 0% of its operating cash flow ($360.04 Billion) in capital expenditures ($42.57 Billion). Check TAK tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Takeda Pharmaceutical Co Ltd ADR Capital Reinvestment Ratio (2000–2025)
This chart tracks Takeda Pharmaceutical Co Ltd ADR's Capital Reinvestment Ratio across 26 annual periods. For the full cash flow conversion analysis, see Takeda Pharmaceutical Co Ltd ADR operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Takeda Pharmaceutical Co Ltd ADR (2000–2025)
Year-by-year Capital Reinvestment Ratio for Takeda Pharmaceutical Co Ltd ADR from 2000 to 2025. See TAK free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.19x | $1.06 Trillion | $200.79 Billion | ▼ -71.7% |
| 2024 | 0.67x | $716.34 Billion | $480.73 Billion | ▲ +3.5% |
| 2023 | 0.65x | $977.16 Billion | $633.69 Billion | ▲ +291.5% |
| 2022 | 0.17x | $1.12 Trillion | $186.04 Billion | ▼ -29.2% |
| 2021 | 0.23x | $1.01 Trillion | $236.47 Billion | ▼ -28.0% |
| 2020 | 0.33x | $669.75 Billion | $217.71 Billion | ▼ -20.4% |
| 2019 | 0.41x | $328.48 Billion | $134.11 Billion | ▲ +20.3% |
| 2018 | 0.34x | $377.85 Billion | $128.26 Billion | ▼ -20.8% |
| 2017 | 0.43x | $261.36 Billion | $112.03 Billion | ▼ -87.1% |
| 2016 | 3.33x | $25.49 Billion | $84.86 Billion | ▲ +458.9% |
| 2015 | 0.60x | $182.52 Billion | $108.72 Billion | ▲ +12.5% |
| 2014 | 0.53x | $148.34 Billion | $78.52 Billion | ▲ +70.1% |
| 2013 | 0.31x | $307.71 Billion | $95.76 Billion | ▲ +69.2% |
| 2012 | 0.18x | $336.57 Billion | $61.90 Billion | ▼ -51.6% |
| 2011 | 0.38x | $326.94 Billion | $124.17 Billion | ▲ +66.5% |
| 2010 | 0.23x | $381.17 Billion | $86.96 Billion | ▲ +88.6% |
| 2009 | 0.12x | $326.27 Billion | $39.46 Billion | ▲ +8.5% |
| 2008 | 0.11x | $292.50 Billion | $32.62 Billion | ▼ -19.9% |
| 2007 | 0.14x | $209.28 Billion | $29.15 Billion | ▲ +62.1% |
| 2006 | 0.09x | $373.57 Billion | $32.09 Billion | ▼ -52.7% |
| 2005 | 0.18x | $295.54 Billion | $53.67 Billion | ▲ +4.3% |
| 2004 | 0.17x | $311.12 Billion | $54.16 Billion | ▲ +37.0% |
| 2003 | 0.13x | $263.45 Billion | $33.48 Billion | ▼ -18.5% |
| 2002 | 0.16x | $240.59 Billion | $37.52 Billion | ▲ +23.1% |
| 2001 | 0.13x | $212.66 Billion | $26.94 Billion | ▼ -43.1% |
| 2000 | 0.22x | $158.96 Billion | $35.42 Billion | — |